Levetiractam in the treatment of two children with myoclonic status epilepticus

被引：11
|
作者：
Haberlandt, E. [1 ]
Sigl, S. Baumgartner [1 ]
Scholl-Buergi, S. [1 ]
Karall, D. [1 ]
Rauchenzauner, M. [1 ]
Rostasy, K. [1 ]
机构：
[1] Med Univ Innsbruck, Dept Pediat, Div Neuropediat & Inherited Metab Disorders, A-6020 Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY | 2009年 / 13卷 / 06期
关键词：
Levetiracetam; Intravenous; Myoclonic status epilepticus; Children; NONCONVULSIVE STATUS EPILEPTICUS; EPILEPSY; PIRACETAM;
D O I：
10.1016/j.ejpn.2008.09.006
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Levetiracetam (LEV) is approved as second line treatment for partial onset seizures in adults and children older than four years of age. Recently, an intravenous formulation was developed as an alternative to standard oral medication. We report the successful treatment of two children suffering from myoclonic status epilepticus with intravenous LEV. Intravenous application of LEV was safe and not associated with significant side effects. In conclusion, intravenous application of LEV appears to be a further option in treatment of children with myoclonic status epilepticus. (C) 2008 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.
引用
收藏
页码：546 / 549
页数：4
相关论文
共 50 条
  • [1] Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam
    Vaca, Guadalupe Fernandez-Baca
    Lenz, Timothy
    Knight, Elia M. Pestana
    Tuxhorn, Ingrid
    EPILEPTIC DISORDERS, 2012, 14 (02) : 155 - 158
  • [2] Myoclonic status epilepticus in juvenile myoclonic epilepsy
    Larch, Julia
    Unterberger, Iris
    Bauer, Gerhard
    Reichsoellner, Johannes
    Kuchukhidze, Giorgi
    Trinka, Eugen
    EPILEPTIC DISORDERS, 2009, 11 (04) : 309 - 314
  • [3] Hemimegalencephaly Accompanied by Myoclonic Status Epilepticus
    Nakashima, Kentarou
    Ogihara, Masaaki
    Kasai-Yoshida, Emi
    Tsuruta, Shio
    Nakagawa, Machiko
    Kusakawa, Isao
    PEDIATRIC NEUROLOGY, 2012, 47 (01) : 55 - 58
  • [4] Levetiracetam for the treatment of status epilepticus
    Zheng, Fangshuo
    Du, Chao
    Wang, Xuefeng
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (10) : 1113 - 1121
  • [5] Levetiracetam in children with refractory status epilepticus
    Gallentine, William B.
    Hunnicutt, Addie S.
    Husain, Aatif M.
    EPILEPSY & BEHAVIOR, 2009, 14 (01) : 215 - 218
  • [6] Two patients with juvenile myoclonic epilepsy and nonconvulsive status epilepticus
    Kimura, S
    Kobayashi, T
    EPILEPSIA, 1996, 37 (03) : 275 - 279
  • [7] Treatment of status epilepticus in children
    De Negri M.
    Baglietto M.G.
    Paediatric Drugs, 2001, 3 (6): : 411 - 420
  • [8] MIDAZOLAM IN THE TREATMENT OF STATUS EPILEPTICUS IN CHILDREN
    RIVERA, R
    SEGNINI, M
    BALTODANO, A
    PEREZ, V
    CRITICAL CARE MEDICINE, 1993, 21 (07) : 991 - 994
  • [9] Oxcarbazepine-induced myoclonic status epilepticus in juvenile myoclonic epilepsy
    Fanella, Martina
    Egeo, Gabriella
    Fattouch, Jinane
    Casciato, Sara
    Lapenta, Leonardo
    Morano, Alessandra
    Giallonardo, Anna Teresa
    Di Bonaventura, Carlo
    EPILEPTIC DISORDERS, 2013, 15 (02) : 181 - 187
  • [10] De Novo Myoclonic Status Epilepticus After Benzodiazepine Withdrawal
    Ferreira Naves, Pedro Vicente
    Calderaro, Marcelo
    Caboclo, Luis Otavio
    CLINICAL NEUROPHARMACOLOGY, 2018, 41 (04) : 142 - 144
12345